Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ferumoxytol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMAG-FER-IDA-301, NCT01114139
A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMAG-FER-IDA-302, NCT01114204
Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMAG-FER-IDA-303, NCT01114217
Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer
Phase: Phase I
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110098, 11-C-0098, NCT01296139
Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000374491, MGH-2004-P-000681/2, NCI-6809, 6809, NCT00087347
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: 2753, NCI-2015-00224, SOL-06062-LX, 813, NCI-2015-00204, 8097, P30CA069533, NCT00660543
Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI
Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-1127, NCI-2013-02182, NCT01895829
Start Over